Advent Life Sciences

Investment thesis

Transatlantic early- to mid-stage life sciences VC founded in 2005, investing in new drug discovery (small molecules, biologics, new modalities), medtech, enabling technologies and vaccines. Works hands-on with management to bring innovative medicines and products to approval, often entering as early as Seed or Series A.

Notable portfolio

Sector focus